• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼古丁暴露与迟发性运动障碍。

Nicotine exposure and tardive dyskinesia.

作者信息

Yassa R, Lal S, Korpassy A, Ally J

出版信息

Biol Psychiatry. 1987 Jan;22(1):67-72. doi: 10.1016/0006-3223(87)90131-4.

DOI:10.1016/0006-3223(87)90131-4
PMID:3790642
Abstract

The prevalence of tardive dyskinesia (TD) in chronic psychiatric outpatients was significantly higher in smokers (46/85) than in nonsmokers (18/69) (p less than 0.001). This increased prevalence was associated with a significantly greater prescribed dose of neuroleptics in women, but not in men. Nicotine increases the synthesis and release of dopamine in the nigrostriatal pathway of animals. Such a mechanism may contribute to the higher prevalence of TD in smokers. The present findings suggest that smoking is a risk factor for the development of TD. A statistically significant association between smoking and TD, however, does not necessarily imply a cause-effect relationship. Treatment of TD with mecamylamine or other central nicotine antagonists merits investigation.

摘要

慢性精神科门诊患者中,迟发性运动障碍(TD)的患病率在吸烟者(46/85)中显著高于非吸烟者(18/69)(p<0.001)。这种患病率的增加在女性中与显著更高剂量的抗精神病药物处方有关,但在男性中并非如此。尼古丁可增加动物黑质纹状体通路中多巴胺的合成和释放。这种机制可能导致吸烟者中TD的患病率更高。目前的研究结果表明,吸烟是TD发生的一个危险因素。然而,吸烟与TD之间具有统计学意义的关联并不一定意味着存在因果关系。用美加明或其他中枢性尼古丁拮抗剂治疗TD值得研究。

相似文献

1
Nicotine exposure and tardive dyskinesia.尼古丁暴露与迟发性运动障碍。
Biol Psychiatry. 1987 Jan;22(1):67-72. doi: 10.1016/0006-3223(87)90131-4.
2
Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia.假说:尼古丁与多巴胺的相互作用将吸烟与帕金森病及迟发性运动障碍联系起来。
Cell Mol Neurobiol. 1988 Sep;8(3):285-91. doi: 10.1007/BF00711170.
3
Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.吸烟与迟发性运动障碍:细胞色素P450 1A2基因未参与其中。
J Psychiatry Neurosci. 2003 May;28(3):185-9.
4
A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.锂盐治疗的情感障碍患者中帕金森综合征和迟发性运动障碍的横断面研究。
J Clin Psychiatry. 1996 Jan;57(1):22-8.
5
Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
Arch Gen Psychiatry. 1982 Apr;39(4):466-9. doi: 10.1001/archpsyc.1982.04290040064009.
6
Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.精神分裂症首发患者迟发性运动障碍的发病率及相关因素
Arch Gen Psychiatry. 1996 Apr;53(4):313-9. doi: 10.1001/archpsyc.1996.01830040049009.
7
Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.确定长期使用抗精神病药物的门诊患者中迟发性运动障碍的风险因素。耶鲁迟发性运动障碍研究的结果。
Arch Gen Psychiatry. 1993 Sep;50(9):723-33. doi: 10.1001/archpsyc.1993.01820210057007.
8
[Neuroleptics and nicotine].[抗精神病药物与尼古丁]
Psychiatr Prax. 1995 Nov;22(6):223-7.
9
High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
Psychopharmacol Bull. 1992;28(1):87-92.
10
Handedness and the risk of tardive dyskinesia.
Biol Psychiatry. 1996 Jul 1;40(1):35-42. doi: 10.1016/0006-3223(95)00357-6.

引用本文的文献

1
Haloperidol - norepinephrine synergy in stimulation of vacuous chewing movements in rats: Enhancement by nicotine.氟哌啶醇与去甲肾上腺素协同刺激大鼠空嚼运动:尼古丁的增强作用
Psychopharmacology (Berl). 2025 Oct 25. doi: 10.1007/s00213-025-06935-3.
2
Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.跨代证据表明啮齿动物多巴胺 D2 受体敏感性增加:对感觉运动门控、尼古丁和 BDNF 的行为反应的影响。
J Psychopharmacol. 2021 Oct;35(10):1188-1203. doi: 10.1177/02698811211033927. Epub 2021 Jul 22.
3
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.
烟碱型乙酰胆碱受体药物在运动障碍中的治疗潜力。
Nicotine Tob Res. 2019 Feb 18;21(3):357-369. doi: 10.1093/ntr/nty063.
4
Medication-Induced Tardive Dyskinesia: A Review and Update.药物性迟发性运动障碍:综述与更新
Ochsner J. 2017 Summer;17(2):162-174.
5
Withdrawal-Emergent Dyskinesias following Varenicline Therapy.伐尼克兰治疗后出现的撤药后运动障碍
Open Neurol J. 2015 May 29;9:7-8. doi: 10.2174/1874205X01509010007. eCollection 2015.
6
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.烟碱胆碱能系统在运动障碍中的作用;治疗意义。
Pharmacol Ther. 2014 Oct;144(1):50-9. doi: 10.1016/j.pharmthera.2014.05.004. Epub 2014 May 14.
7
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study.抗精神病药物与门诊精神分裂症患者的烟草使用:一项横断面研究。
Ann Gen Psychiatry. 2014 Mar 19;13(1):7. doi: 10.1186/1744-859X-13-7.
8
Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.尼古丁可减少大鼠抗精神病药引起的口腔运动障碍。
J Pharmacol Exp Ther. 2012 Mar;340(3):612-9. doi: 10.1124/jpet.111.189100. Epub 2011 Dec 5.
9
Movement disorders: neurodevelopment and neurobehavioural expression.运动障碍:神经发育与神经行为表现
J Neural Transm (Vienna). 2007;114(4):XXXIII-XLI. doi: 10.1007/s00702-006-0572-9. Epub 2006 Oct 6.
10
Co-morbidity of smoking in patients with psychiatric and substance use disorders.精神疾病和物质使用障碍患者中吸烟的共病情况。
Am J Addict. 2005 Mar-Apr;14(2):106-23. doi: 10.1080/10550490590924728.